Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on etanercept therapy in rheumatic diseases
Etanercept is a biologic medication used to treat various rheumatic diseases, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. It works by inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By blocking TNF, Etanercept helps reduce inflammation, pain, and joint damage.
In rheumatoid arthritis, Etanercept has shown to significantly improve symptoms and slow disease progression. Patients experience relief from joint stiffness, swelling, and pain, leading to better physical function. It is often prescribed when other treatments, like methotrexate, do not provide sufficient results.
For psoriatic arthritis and ankylosing spondylitis, Etanercept also offers benefits by reducing joint inflammation and preventing further joint damage. It helps improve mobility and overall quality of life. However, long-term use requires regular monitoring, as it can increase the risk of infections and other side effects.
Overall, Etanercept provides an effective treatment option for patients with rheumatic diseases, especially when conventional therapies fall short.
Therefore, get an overall knowledge of etanercept therapy in rheumatic diseases. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Beyond What Is Visible in Myelofibrosis?
2.
FDA approves rivanetin as the first-line treatment for lung cancer.
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
Certain surgical gestures during prostate removal linked to better sexual function recovery
1.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
2.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
3.
Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review
4.
Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics
5.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation